Literature DB >> 28401404

Controversy about Management of Hydrocephalus - Shunt vs. Endoscopic Third Ventriculostomy.

Vikas Kumar1, Shaam Bodeliwala1, Daljit Singh2.   

Abstract

The best management of hydrocephalus is still controversial in the twenty-first century. Shunt treatment for hydrocephalus is the most common procedure performed in neurosurgical practice and is associated with the highest complications rate. But during the last 2 decades, the treatment of hydrocephalus has improved with better shunt devices available today, increased facilities for investigations and newer approaches like endoscopic third ventriculostomy. The recent advances in development of better endoscopes have provided the patient and treating doctor with an option for an alternative surgery for treatment of hydrocephalus.

Entities:  

Keywords:  Endoscopic third ventriculostomy; Hydrocephalus; Ventriculoatrial shunt; Ventriculoperitoneal shunt

Mesh:

Year:  2017        PMID: 28401404     DOI: 10.1007/s12098-017-2338-9

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  43 in total

1.  Endoscopic third ventriculostomy in patients with malfunctioning CSF-shunt.

Authors:  Armen Melikian; Anton Korshunov
Journal:  World Neurosurg       Date:  2011-01-12       Impact factor: 2.104

2.  Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric patients: a decision analysis.

Authors:  James M Drake; Abhaya V Kulkarni; John Kestle
Journal:  Childs Nerv Syst       Date:  2009-01-13       Impact factor: 1.475

3.  The scientific history of hydrocephalus and its treatment.

Authors:  A Aschoff; P Kremer; B Hashemi; S Kunze
Journal:  Neurosurg Rev       Date:  1999-10       Impact factor: 3.042

4.  Success of endoscopic third ventriculostomy in children less than 2 years of age.

Authors:  Volkan Etus; Savas Ceylan
Journal:  Neurosurg Rev       Date:  2005-07-22       Impact factor: 3.042

Review 5.  Shunts vs endoscopic third ventriculostomy in infants: are there different types and/or rates of complications? A review.

Authors:  C Di Rocco; L Massimi; G Tamburrini
Journal:  Childs Nerv Syst       Date:  2006-10-20       Impact factor: 1.475

6.  Management of adult hydrocephalus with ventriculoperitoneal shunts: long-term single-institution experience.

Authors:  G Kesava Reddy; Papireddy Bollam; Runhua Shi; Bharat Guthikonda; Anil Nanda
Journal:  Neurosurgery       Date:  2011-10       Impact factor: 4.654

7.  Endoscopic third ventriculostomy in post-tubercular meningitic hydrocephalus: a preliminary report.

Authors:  D Singh; V Sachdev; A K Singh; S Sinha
Journal:  Minim Invasive Neurosurg       Date:  2005-02

8.  Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus.

Authors:  Abhaya V Kulkarni; James M Drake; Conor L Mallucci; Spyros Sgouros; Jonathan Roth; Shlomi Constantini
Journal:  J Pediatr       Date:  2009-05-15       Impact factor: 4.406

9.  Ventriculoperitoneal shunt complications in California: 1990 to 2000.

Authors:  Yvonne Wu; Nella L Green; Margaret R Wrensch; Shoujun Zhao; Nalin Gupta
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

Review 10.  Selecting patients for endoscopic third ventriculostomy.

Authors:  Harold L Rekate
Journal:  Neurosurg Clin N Am       Date:  2004-01       Impact factor: 2.509

View more
  3 in total

1.  Recent Advances and Controversies in Pediatric Surgery.

Authors:  Yogesh Kumar Sarin
Journal:  Indian J Pediatr       Date:  2017-06-14       Impact factor: 1.967

2.  [Placement of ventricle peritoneal shunt in the adult patient. A new protocol].

Authors:  Juan F Villalonga; Sebastián Giovannini; Guido Caffaratti; Emiliano Lorefice; Tomás Ries Centeno; Francisco Marcó Del Pont
Journal:  Surg Neurol Int       Date:  2019-08-02

3.  Long-standing overt ventriculomegaly in adulthood with primary presentation of psychiatric disturbance: A case report.

Authors:  Gao-Jian Su; Jie Gao; Chu-Wei Wu; Jun-Feng Zou; Dong-Liang Zhu; Jun Liu; Jie-Hua Zhang; Xian-Jian Huang
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.